Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330:1449-1450 (18 June), doi:10.1136/bmj.330.7505.1449-c
| The first 150 words of the full text of this article appear below. |
EDITORLawton et al describe perceptions of oral hypoglycaemic agents among people of Pakistani and Indian origin.1 We have observed another phenomenon quite often among patients. When treatment is started in asymptomatic patients with high blood pressure or high plasma glucose picked up on screening the general population, some patients believe that the treatment is necessary only to bring the blood pressure or the plasma glucose within the normal range. At review they say that they have stopped taking the treatment because they were told that blood pressure or plasma glucose concentration had been normal the previous time. We find ourselves repeating the message that the blood pressure, blood glucose, or the HbA1C is within the normal range because of the treatment; hence if they stop taking the drugs the variables will go up again. We have observed this phenomenon more in South Asians than white people.
Although
K Kain, senior lecturer in community diabetes
k.kain@leeds.ac.uk
Academic Unit of Molecular Vascular Medicine Level 7, The LIGHT Laboratories, Clarendon Way, University of Leeds, Leeds LS2 9JT
A J Catto, senior lecturer
Academic Unit of Molecular Vascular Medicine Level 7, The LIGHT Laboratories, Clarendon Way, University of Leeds, Leeds LS2 9JT